Libai Foundation - Health Built Different.
● Breaking
Takeda Launches First Orexin Agonist for Narcolepsy Type 1
● Top Story
Policy Watch

Takeda Launches First Orexin Agonist for Narcolepsy Type 1

Takeda introduces Orzeyful, the first orexin agonist targeting narcolepsy type 1's underlying deficiency, now FDA-approved for adults.

Clinical Findings

Medical costs may increase expected pain levels

Medical costs may increase expected pain levels, potentially discouraging patients from care,…

Mental Wellness

NICE backs non-hormonal treatment for hot flashes

NICE backs a non hormonal treatment for hot flashes and night sweats,…

Clinical Findings

New Pharmacy Technician Curriculum Risks Higher Dropouts

The pharmacy technician curriculum revisions warned by the CCA may increase student…

Clinical Findings

Government slow to act on valproate redress

Government slow to act on sodium valproate redress, addressing harms caused to…

Mental Wellness

More →
NICE backs non-hormonal treatment for hot flashes
Mental Wellness

NICE backs non-hormonal treatment for hot flashes

Mental Wellness

Scottish pharmacists boost menopause support with peer-led clinics

Mental Wellness

Scotland launches first drug-checking service

Mental Wellness

Prescribing error blamed in infant death sparks safety review

Clinical Findings

More →
Medical costs may increase expected pain levels
Clinical Findings

Medical costs may increase expected pain levels

Clinical Findings

New Pharmacy Technician Curriculum Risks Higher Dropouts

Clinical Findings

Government slow to act on valproate redress

Clinical Findings

UK pharmacies to get fairer funding

Policy Watch

More →
Takeda Launches First Orexin Agonist for Narcolepsy Type 1
Policy Watch

Takeda Launches First Orexin Agonist for Narcolepsy Type 1

Policy Watch

Rural heart attack patients far more likely to die

Policy Watch

New tech aids mental health diagnosis

Patient Advocacy

More →
NHS to offer Enhertu to breast cancer patients
Patient Advocacy

NHS to offer Enhertu to breast cancer patients

Patient Advocacy

Former Star Pitcher Urges Cholesterol Checks After Heart Procedure

Patient Advocacy

Anxiety Affects One Fifth of U.S. Young Adults

Patient Advocacy

Smartphone use hurts teens sleep patterns

Research Briefs

More →
MHRA Issues Recall on ACE Inhibitor Blister Packs
Research Briefs

MHRA Issues Recall on ACE Inhibitor Blister Packs

Research Briefs

Liberal Democrats vow to boost Pharmacy First service

Research Briefs

Pharmacies Expect Surge in Weight Loss Pill Demand

Research Briefs

Kids on GLP-1 Drugs Face Nutritional Deficiency Risks